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Abstract: Healthcare-associated infections (HAI) are a huge public health concern, 
particularly when the etiological agents are multidrug resistant. The ability of bacteria to 
develop biofilm is a helpful skill, both to persist within hospital units and to increase 
antibiotic resistance. Although the links between antibiotic resistance, biofilms assembly 
and HAI are consensual, little is known about biofilms. Here, electron microscopy was 
adopted as a tool to investigate biofilm structures associated with increased antibiotic 
resistance. The K. pneumoniae strains investigated are able to assemble biofilms, albeit 
with different kinetics. The biofilm structure and the relative area fractions of bacteria and 
extracellular matrix depend on the particular strain, as well as the minimal inhibitory 
concentration (MIC) for the antibiotics. Increased values were found for bacteria organized 
in biofilms when compared to the respective planktonic forms, except for isolates Kp45 
and Kp2948, the MIC values for which remained unchanged for fosfomycin. Altogether, 
these results showed that the emergence of antimicrobial resistance among bacteria 
responsible for HAI is a multifactorial phenomenon dependent on antibiotics and on 
bacteria/biofilm features.  
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1. Introduction 
In recent years, healthcare-associated infections (HAI), defined as infections occurring after exposure 
to healthcare, but not always as a consequence of this exposure, have been reported as a major  
public health problem. In 2012, the European Centre for Disease Control (ECDC) has estimated that  
at least 2.6 million cases of HAI occur annually in long-term care facilities. This number adds to  
the previously estimated 4.1 million cases in acute-care hospitals, which result in 37,000 annual deaths  
in Europe [1]. 
The incidence of HAI varies with body site and is determined to a large extent by the underlying 
disease condition of patients (e.g., immunosuppression) in addition to their exposure to high-risk 
medical interventions, such as surgery or invasive diagnostic procedures. Nevertheless, the main 
infection sites are the urinary and lower respiratory tracts, surgical sites and the bloodstream. 
Treatment of HAI is challenging due to the prevalence of antibiotic-resistant bacteria [2], and their 
ability to assemble biofilms can worsen the situation turning HAI refractory to antibiotherapy. Biofilm 
is defined as a thin layer of microorganisms and secreted polymers adhering to a biotic or abiotic 
surface, presenting an internal organization that evolves over time. Biofilms tend to increase bacterial 
resistance to host defense mechanisms, antibiotics, sterilization procedures (other than autoclaving) 
and the persistence in water distribution systems and in generic surfaces [3].  
Biofilm-associated microorganisms have been related with several human diseases and are known 
to colonize a wide variety of medical devices [4]. Klebsiella pneumoniae is a worldwide leading cause 
of hospital-acquired urinary tract infections, as well as pneumonia, being responsible for many cases of 
pyogenic liver abscess or endophthalmitis contracted in community patients [5]. The incidence of  
K. pneumoniae infections increased in hospitals and, according to the latest data from ECDC, was 
included among the six ESKAPE bacteria responsible for two-thirds of all HAIs. The ESKAPE 
pathogens are multi-drug resistant strains of Enterococcus faecium, Staphylococcus aureus, Klebsiella 
species, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species [6]. In spite of 
their close relation, one notable difference between K. pneumoniae and the other members of HAIs is 
the extremely thick, hypermucoviscous, extracellular polysaccharide capsule. Virulent strains have 
been predominantly associated with the K:1 and K:2 capsular serotypes. The capsule is believed to be 
a major virulence determinant by protecting K. pneumoniae against phagocytosis and destruction by 
antimicrobial peptides [7,8]. Other virulence factors have provided new insights into the pathogenic 
strategies of K. pneumoniae, such as fimbriae type 1 and type 3, which mediate attachment to the host 
mucosal surfaces and inert surfaces [9,10]. In addition, the incidence of isolation of antibiotic-resistant  
K. pneumoniae has increased in recent years, thus complicating the therapy of HAIs and community 
infections. Research into new antibiotics, phage therapy and vaccines has been some of the features of 
the past decade. There is now a pressing need for new therapeutic approaches, given the increased 
number of multi-resistant bacteria (MRB). Here, we focus on the role played by biofilm organization 
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on antibiotic resistance. A deeper understanding of this topic is the first step towards the development 
of more effective, either preventive of curative, approaches to minimize the impact of HAI. 
2. Results and Discussion 
2.1. Bacteria Characterization 
Ten K. pneumoniae MRB were collected at Lisboa hospitals, between 1980 and 2011 (Table 1). 
Kp45 and Kp26 strains were isolated, from a nurse neck swab and from a newborn rectal swab, 
respectively, during a colonization study at a neonatology ward. These isolates showed the same 
capsular type, K:2. The non-capsulated Kp703 strain was isolated from the urine of a burn patient, and 
its bacterial surface carbohydrates (O antigen) were typed as O:1. From the remaining isolates, only 
Kp2948 showed capsular type K:2. 
Table 1. Characteristics of Klebsiella pneumoniae multidrug-resistant isolates  
producing 

-lactamases. 
Strain Source Year Serologic Group Fimbriae  -lactamases 
Kp45 Neck swab 
1980 
K:2 fimH mrkD TEM-1 
Kp26 Rectal swab K:2 n.a. n.a. TEM-1 
Kp703 
Urine 
O:1 n.a. mrkD TEM-1 
Kp3921 
2010 
n.a. fimH mrkD CTX-M-15 
Kp2948 Wound K:2 fimH mrkD KPC-3; TEM-1 
Kp3421 
Urine 2011 
n.a. fimH mrkD CTX-M-15 
Kp3407 n.a. fimH mrkD KPC-3 
Kp3466 n.a. n.a. n.a. TEM-163 
Kp3385 n.a. fimH mrkD KPC-3 
n.a.: no amplification. 
Various fimbrial adhesins have been shown to play a role in biofilm formation [11]. Most  
K. pneumoniae isolates express two types of fimbrial adhesins: type 1 and type 3. In this study, all 
strains, except Kp26 and Kp3466, were amplified for fimH and mrkD gene subunits of the type 1 and 
type 3 fimbrial adhesins, respectively. It should be emphasized that the fimH gene was not found in the 
non-capsulated K. pneumoniae Kp703 strain (Table 1). 
The main difference between K. pneumoniae strains isolated in 1980 and twenty years later is  
the antimicrobial resistance; isolates from 1980 were susceptible to all cephalosporins and produced  
a broad spectrum 

-lactamase TEM-1, while isolates from 2010 to 2011 have evolved to encode 
extended-spectrum 

-lactamases CTX-M-15 and TEM-163, which confer resistance to extended-spectrum 
cephalosporins, with the hallmark being the resistance to ceftazidime and cefotaxime. The Kp2948  
and Kp3385 isolates exhibit increased resistance to carbapenem antibiotics, producing KPC-3 
carbapenemase. All strains have acquired resistance mechanisms to other classes of antibiotics and  
are considered MRB. 
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2.2. Biofilm Assembly 
The bacterial ability to assemble biofilms on cell culture plates was evaluated. All strains were able 
to assemble biofilms, although following different kinetics (Figure 1A). The strains were divided into 
two main groups according to biofilm evolution. Group 1 includes the strains for which the three major 
biofilm assembly stages could be clearly identified before 48 h of culture, namely adhesion, maturation 
and dispersion: Kp703, Kp45, Kp3921, Kp3466, Kp3391, Kp3407 and Kp26. Group 2 comprises
Kp2948, Kp3421 and Kp3385, which did not reach the dispersion stage at 48 h. 
Figure 1. The kinetics of biofilm assembly by 10 strains of K. pneumoniae was followed 
over 48 h using a spectrophotometric assay (A); in parallel, scanning electron microscopy 
(B,C) was used to illustrate biofilm assembly. Representative micrographs of 12 h-old 
biofilms of kp703 (B) and Kp2948 (C) show the different ability to assemble biofilms 
exhibited by these strains. The presence of organized bacterial structures is highlighted by 
arrowheads (B). Scale bar:    	 
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The most efficient biofilm assemblers were selected from each group for detailed study: Kp703 and 
Kp45 from Group 1 and Kp2948 from Group 2. K. pneumoniae strains Kp703 and Kp45 followed 
similar kinetics with comparable biomass increase (Figure 1A), although these strains differ in capsule 
expression; Kp703 is non-capsulated (O:1), while Kp45 is capsulated (K:2) (Table 1). 
The Kp2948 strain selected from Group 2 shared several features with Kp45, such as the presence of 
a K:2 capsule and type 1 (fimH) and type 3 (mrkD) fimbriae; nonetheless Kp2948 exhibited distinct 
biofilm assembly kinetics (Table 1). Both capsulated strains exhibited longer adaptation phases, 
supporting the previous findings of the downregulation of type 1 fimbriae [9]. On the other hand, the  
non-capsulated Kp703 strain had a shorter adaptation phase with a faster increase of biomass. The 
absence of type 1 fimbriae and the presence of type 3 fimbriae may account for the observed difference 
in kinetics. Type 3 fimbriae are known to be important, both for initial cell-surface attachment and for 
the cell-cell adherence mediation in the biofilm [9]. 
2.3. Scanning Electron Microscopy 
Scanning electron microscopy (SEM) highlighted the differences between the biofilms assembled 
by the selected bacterial strains. Micrographs of 12 h-old biofilms are shown in Figure 1. The Kp703 
biofilm is fully mature with clear bacterial complexes highlighted by arrowheads in Figure 1B. The 
Kp2948 biofilm showed few bacteria attached to the surface (Figure 1C), supporting the assumption 
that this isolate is in a different stage of biofilm assembly (Figure 1A).  
In order to further characterize the internal organization, biofilm cross-sections were observed  
in backscattered electron mode after staining with heavy metals. This experimental approach has 
advantages and disadvantages when compared with transmission electron microscopy (TEM) 
observations; on the one hand, it is less time consuming and allows larger fields of view; on the other 
hand, the resolution attained is lower [12]. The method was used to assess the evolution of the relative  
area fractions of bacteria and extracellular matrix (EPS) as inferred from the cross-sectional areas.  
A representative micrograph of a 4 h-old Kp703 biofilm is shown in Figure 2A, where EPS is 
indicated by arrowheads. The results obtained from the analysis of biofilms at different maturation 
stages are shown in Figure 2B,C, where it is evident that the relative area fraction of bacteria depends 
consistently on the strain: Kp703 biofilms have higher amounts of bacteria (Figure 2B) than Kp45 
biofilms (Figure 2C). In good agreement with the biofilm assay (Figure 1A) and the SEM micrographs 
shown in Figure 1B, the Kp703 strain was associated with the highest biomass at all stages of biofilm 
assembly (Figure 2B). At 4, 12 and 24 h, the relative area occupied by Kp45 biofilms is statistically 
smaller (p < 0.010) than in both Kp703 and Kp2948 biofilms. In fact, the relative bacterial areas for 
the most and least efficient biofilm assembler (Kp703 and Kp2948, respectively) only differ at later 
stages, when the relative area occupied by Kp703 becomes bigger than the one taken by Kp2948  
(p < 0.039). These data suggest that Kp703 and Kp2948 assembled similar biofilms, although 
following different kinetics. The intermediate biofilm assembler (Kp45) registered the lowest bacterial 
areas for all culture times. Altogether, these results showed that Kp45 biofilm is unique although 
assembled with a kinetic similar to Kp703 biofilm (Figure 1A). 
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Figure 2. The biofilms assembled by three K. pneumoniae strains (Kp45, Kp703 and 
Kp2948) were characterized using SEM in backscattered electron mode. The existence of 
extracellular matrix (arrow heads) surrounding bacteria from early stages is highlighted by 
arrow heads in a 4 h-old Kp703 micrograph (A). The relative areas occupied by bacteria  
(B) and extracellular matrix (C) during the different phases of biofilm assembly were 
assessed. The differences were considered significant for p < 0.05 (* p < 0.05; ** p < 0.01). 
Scale bar:   	 
  
 
 
 
The area fraction of EPS (Figure 2C), a key player in biofilm assembly and persistence, was also 
determined from cross-sectional observations. Kp45 excreted significantly more EPS when compared 
to Kp2948 for all culture times (p < 0.048). The EPS relative area fraction in the Kp703 biofilm was 
always lower than in the Kp45 biofilm; nevertheless, the difference was significant only at 12 and 24 h.
No differences between the EPS relative area fractions of Kp703 and Kp2948 were detected. This fact 
supports the previous assumption that these two strains form similar biofilms, although following 
different kinetics. The EPS amount was not uniform in each biofilm and may be altered in space and 
time, proving that different bacteria produce it in different amounts [3]. The EPS content within 
biofilm varies over time, with the highest amount at the attachment and dispersion phases. Studies 
have shown that EPS plays an important role in attachment and dispersion phases, binding cells to a 
surface [3,13]. It should be remembered that the dispersion stage occurs due to a local nutrient 
depletion, triggering bacteria to colonize other areas from the surface [3]. Extracellular matrix contributes
              

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to the increased virulence of microorganisms, blocking mass transport of antibiotics through the 
biofilm [3] and hampering the elimination of infection by the immune system and antimicrobials.  
2.4. Antimicrobial Activity of Planktonic and Biofilm-Embedded K. pneumoniae Strains 
Biofilms can physically protect bacteria from antimicrobial exposure when compared with planktonic 
forms, it being important to develop accurate methodologies to determine the MIC for K. pneumoniae  
strains embedded in the respective biofilms.  
The MIC values found were different according to antibiotics and bacteria. In general, an increase 
of MICs for bacteria in biofilm form was verified (Table 2). The increase in MIC values for 
amoxicillin ranged from five- to 10-fold. The source of 

-lactamases in biofilms has been attributed to 
bacteria lysis promoted by antibiotics. These enzymes once secreted maintain their activity within the 
biofilm matrix, hydrolyzing 

-lactam antibiotics before these drugs reach the bacterial cells [14]. 
Antibiotics penetration within biofilms could be hampered by other factors, such as the presence of 
negatively-charged surfaces, particularly for large polar molecules that are positively charged, e.g., 
aminoglycosides [15]. In addition, limited oxygen and metabolic rates are probably important factors 
contributing to increased bacterial aminoglycosides tolerance. Altogether, these factors could account 
for the variation of two-, eight- and 250-fold in MIC values for gentamicin for K. pneumoniae isolate 
Kp2948, Kp45 and Kp703 biofilms when compared to the planktonic forms, respectively. In contrast 
to amoxicillin and gentamicin, fosfomycin is known to penetrate through biofilm layers [16]. In the 
present study, only Kp703 increased the MIC value 1000-fold for fosfomycin between planktonic and 
biofilm forms. The other K. pneumoniae strains retained unchanged MIC values for this antibiotic. 
This apparently unexpected result could be explained by the presence/absence of a capsule. Both 
capsulated strains (Kp45 and Kp2948) expressing capsular type K:2 showed unchanged MIC values of 
0.781 µg/mL, whereas the non-capsulated Kp703 strain registered the most significant increase. The 
isolate Kp2948 producing carbapenemase KPC-3 is resistant in vitro to all 

-lactams, including  

-lactam/

-lactamase inhibitor combinations, quinolones and aminoglycosides [17]. The therapeutic 
options are often limited to tigecycline and colistin, although this strain has moderate susceptibility to 
these antibiotics and shows susceptibility to fosfomycin (data not shown). In summary, fosfomycin 
demonstrated in vitro activity against the KPC-producing K. pneumoniae isolate in planktonic and 
biofilm forms.   ﬀ ﬁ  	 ﬂ ﬃ    ﬀ !  "  # $ % !  &  	  ﬃ '  (  ! # & ) ! & ' ! *  $ ly penetrates tissues [18] and could 
represent a possible alternative to tigecycline and colistin, minimizing the impact of HAI.  
Factors affecting biofilm formation were not evaluated in this study. Several genes involved  
in biofilm formation by K. pneumoniae were described, which account for the production of 
exopolysaccharides, lipopolysaccharides and capsule, as well as the cell density-dependent regulation 
by quorum sensing [19]. 
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Table 2. Comparison of minimal inhibitory concentration (MIC) obtained for planktonic 
and biofilm-organized K. pneumoniae. 
A: MIC (Planktonic) 
Drug 
Strain 
Amoxicillin 
+ , - . / 0 1
 
Fosfomycin 
+ , - . / 0 1
 
Gentamicin 
+ , - . / 0 1
 
Kp45 250 0.781 3.05 
Kp703 250 <0.488 0.760 
Kp2948 >500 0.781 1.52 
B: MIC (Biofilm) 
Drug 
Strain 
Amoxicillin 
+ , - . / 0 1
 
Fosfomycin 
+ , - . / 0 1
 
Gentamicin 
+ , - . / 0 1
 
Kp45 >2,500 0.781 24.4 
Kp703 >2,500 500 195 
Kp2948 2,500 0.781 3.05 
3. Experimental Section  
3.1. Bacterial Strains 
Ten Klebsiella pneumoniae multiresistant strains were isolated from biological products and  
are part of the FFUL (Faculty of Pharmacy ULisboa, Lisboa, Portugal) collection. All strains were 
from healthcare-associated infections.  
3.2. Capsular Type 
Three K. pneumoniae isolates identified in 1980 (Kp 45, Kp26, Kp703) were typed at the World 
Health Organization International Escherichia and Klebsiella Centre, Copenhagen, Denmark. The 
detection of capsular type K:1 and K:2 for remaining isolates were performed by PCR using specific 
primers for rmpA [20] and K2a [21] genes, respectively.  
3.3. Biofilm Assay 
The assay was performed in triplicate using 96-well flat-bottomed cell culture plates (Nunc, New 
York, NY, USA) as described previously with small modifications [22]. Briefly, K. pneumoniae 
suspensions at a final concentration of 10
7
 CFU/mL were prepared in 0.9% sodium chloride from 
overnight cultures in Mueller2 Hinton (MH) agar and ten-fold diluted in MH broth (Oxoid, 
Basingstoke, UK). Two-hundred microliters were distributed to each well, MH broth being used as the 
negative control. The plates were incubated at 37 °C to allow biofilm formation for different time 
periods. Then, the content of each well was removed, and each well was vigorously washed three times 
with sterile distilled water to remove non-adherent bacteria. The attached bacteria were stained for 15 
min with 100  3  of violet crystal at room temperature, washed with distilled water three times to 
remove excess dye and allowed to dry at room temperature. The violet crystal was dissolved in 100  3  
of 95% ethanol (Merck, Damstadt, Germany), and the optical density at 570 nm was read using a 
(SpectraMax 340PC; Molecular Devices, Sunnyvale, CA, USA). 
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3.4. Scanning Electron Microscopy (SEM) 
For SEM analysis, biofilms were allowed to form on six-well cell culture plates (Nunc) for 12 h at 
37 °C. The biofilm was fixed with 2.5% glutaraldehyde (EMS, Hatfield, PA, USA), 4% 
paraformaldehyde (Sigma, St Louis, MO, USA) and 0.05% ruthenium red (Sigma) in 0.1 M cacodylate 
buffer, pH 7.2, overnight, at 4 °C. This was followed by post-fixation in the dark with 1% osmium 
tetroxide (EMS), 0.05% ruthenium red and then washed twice with cacodylate and water [23], 
dehydrated, transferred to glass slides (bioMérieux, 4 ! ' ﬃ ﬂ # 5 6 &   # 7 , France) and allowed to dry at room 
temperature. For backscattered electron analysis, samples were further embedded in Epon812 epoxy 
resin (EMS) and allowed to polymerize at 65 °C for 3 days. Once polymerized, the blocks were 
trimmed and sectioned using an ultramicrotome (Leica, Solms, Germany). Thin sections were 
transferred to coverslips coated with 0.5% (m/v) gelatine (Sigma) and 0.05% (m/v) chromium 
potassium sulfate dodecahydrate (Panreac, St Loius, MO, USA) and allowed to dry at room 
temperature. The sections were contrasted with saturated uranyl acetate in water, for 30 min, followed 
by Reynolds lead citrate for 3 min. 
Samples were mounted on the sample holder with carbon tape, sputter-coated with carbon (20 nm) 
using a Sputter Coater QISOT ES (Quorum Technologies, Laughton, UK) and analyzed under an 
electron microscope, JSM-7100F (JEOL, Tokyo, Japan). 
3.5. Antibiotic Susceptibility Test 
The antimicrobial activity was evaluated by the micro-dilution method according to Clinical and 
Laboratory Standards Institute guidelines, using amoxicillin (Bio-Rad, Hercules, CA, USA), fosfomycin  
(Bio-Rad) and gentamicin (Gibco, New York, NY, USA). Briefly, antibiotics were diluted in MH 
broth to produce a two-fold dilution in the concentration ranges from 10,000 to 0.0048 µg/mL for 
amoxicillin, 500 to 0.244 µg/mL for fosfomycin and 12,500 to 0.191 µg/mL for gentamicin. A positive 
control containing a suspension of bacteria in MH broth without antibiotics was performed in parallel. 
The minimum inhibitory concentration (MIC) was defined as the lowest concentration of antibiotic 
resulting in the absence of turbidity after over-night incubation at 37 °C. 
The MIC for biofilm was performed using the same antibiotics and concentrations. Briefly, a 
biofilm was allowed to form as described in Section 3.2 during 12 h. After removing the non-adherent 
bacteria, the antibiotic solutions were added, and the plate was sonicated in a water table sonicator for  
5 min and incubated over-night at 37 °C. 
3.6. Statistical Analysis 
The results of at least three independent experiments were expressed as the means ± standard 
deviation (SD). SEM micrographs were analyzed using Image J software with the statistical 
significance assessed by the Student t-test (two-tailed). A p-value of <0.05 (*) and <0.01 (**) were 
considered statistically significant. 
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4. Conclusions  
This study supports the hypothesis that biofilms formed on medical devices can promote the onset 
and enhance the spread of HAIs. The biofilm assembly process is bacterial type specific.  
Biofilm-forming bacteria are generally more resistant to antibiotics; however, fosfomycin 
demonstrated in vitro activity against KPC-producing K. pneumoniae isolate, both in planktonic and 
biofilm forms. The emergence of antimicrobial resistance among bacteria responsible for HAIs is a 
multifactorial phenomenon dependent on antibiotics and bacteria/biofilm features. Therefore, 
elucidating the biofilm-forming ability and evaluating the structural organization of biofilms and the 
susceptibility to antimicrobials are crucial for the development of treatment regimens. 
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